Phanes Therapeutics is an innovative biotech company with a strong discovery pipeline in metabolic complications and oncology. We are currently collaborating with 10 different companies located in US and China on our programs and continue to build additional collaborations to advance our pipeline.  We are interested in seeking partnerships with companies focused on late clinical development and commercialization to advance our programs by leveraging both companies’ strengths.